ArticleCureus2026
Facial Nerve Paralysis Revealing Adenosquamous Carcinoma of the Parotid Gland: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenosquamous carcinoma (ASC) of the salivary glands is a rare and aggressive malignancy. We report the case of a patient who presented to the otorhinolaryngology department with a two-month history of left parotid swelling associated with peripheral facial nerve paralysis. Imaging revealed an ill-defined, expansive lesion of the left parotid gland with intracranial extension and heterogeneous enhancement following intravenous contrast administration, along with concomitant pulmonary metastases. A surgical biopsy confirmed the diagnosis of primary ASC of the salivary gland. The patient was treated with chemotherapy, with follow-up demonstrating a reduction in the size of the primary tumor and regression of pulmonary metastases. This report highlights the aggressive behavior of this rare entity and underscores the essential role of imaging in its diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.